Works matching DE "AMYOTROPHIC lateral sclerosis treatment"

Results: 517

Transitioning a Chronically Ventilator-Dependent Patient Home From a Community Hospital: An Interdisciplinary Approach.

Published in:

Canadian Journal of Critical Care Nursing, 2016, v. 27, n. 2, p. 27

By:

Marr, Shirley;
Klages, Robyn;
Capolongo, Domenico

Publication type:

Article

Amyotrophe Lateralsklerose.

Published in:

Anaesthesiologie & Intensivmedizin, 2022, v. 63, n. 12, p. 504

By:

Gaik, C.;
Wiesmann, T.

Publication type:

Article

Long‐term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS.

Published in:

Annals of Clinical & Translational Neurology, 2018, v. 5, n. 6, p. 730, doi. 10.1002/acn3.567

By:

Goutman, Stephen A.;
Brown, Morton B.;
Glass, Jonathan D.;
Boulis, Nicholas M.;
Johe, Karl;
Hazel, Tom;
Cudkowicz, Merit;
Atassi, Nazem;
Borges, Lawrence;
Patil, Parag G.;
Sakowski, Stacey A.;
Feldman, Eva L.

Publication type:

Article

Predicting disease progression in amyotrophic lateral sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2016, v. 3, n. 11, p. 866, doi. 10.1002/acn3.348

By:

Taylor, Albert A.;
Fournier, Christina;
Polak, Meraida;
Wang, Liuxia;
Zach, Neta;
Keymer, Mike;
Glass, Jonathan D.;
Ennist, David L.

Publication type:

Article

Gamma-synuclein pathology in amyotrophic lateral sclerosis.

Published in:

Annals of Clinical & Translational Neurology, 2015, v. 2, n. 1, p. 29, doi. 10.1002/acn3.143

By:

Peters, Owen M.;
Shelkovnikova, Tatyana;
Highley, John Robin;
Cooper‐Knock, Johnathan;
Hortobágyi, Tibor;
Troakes, Claire;
Ninkina, Natalia;
Buchman, Vladimir L.

Publication type:

Article

Relationship of statins and other cholesterol-lowering medications and risk of amyotrophic lateral sclerosis in the US elderly.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 7/8, p. 538, doi. 10.1080/21678421.2018.1511731

By:

Freedman, D. Michal;
Kuncl, Ralph W.;
Cahoon, Elizabeth K.;
Rivera, Donna R.;
Pfeiffer, Ruth M.

Publication type:

Article

Hope and self-efficacy are associated with better satisfaction with life in people with ALS.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 7/8, p. 611, doi. 10.1080/21678421.2018.1476546

By:

Galin, Shir;
Heruti, Irit;
Barak, Noa;
Gotkine, Marc

Publication type:

Article

Co-occurrence of MS and ALS: a clue in favor of common pathophysiological findings?

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 7/8, p. 500, doi. 10.1080/21678421.2018.1476547

By:

Guennoc, Anne-marie;
Pallix-guyot, Maud;
Le Page, Emmanuelle;
Le Port, Damien;
Daryabin, Mathieu;
Hergesheimer, Rudolph;
Beltran, Stéphane;
Tourbah, Ayman;
Edan, Gilles;
Corcia, Philippe

Publication type:

Article

Riluzole does not improve lifespan or motor function in three ALS mouse models.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 5/6, p. 438, doi. 10.1080/21678421.2017.1407796

By:

Hogg, Marion C.;
Halang, Luise;
Woods, Ina;
Coughlan, Karen S.;
PREHN, Jochen H. M.

Publication type:

Article

An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 3/4, p. 242, doi. 10.1080/21678421.2017.1421666

By:

Fournier, Christina N.;
Schoenfeld, David;
Berry, James D.;
Cudkowicz, Merit E.;
Chan, James;
Quinn, Colin;
Brown, Robert H.;
Salameh, Johnny S.;
Tansey, Malu G.;
Beers, David R.;
Appel, Stanley H.;
Glass, Jonathan D.

Publication type:

Article

VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 3/4, p. 259, doi. 10.1080/21678421.2018.1426770

By:

Andrews, Jinsy A.;
Cudkowicz, Merit E.;
Hardiman, Orla;
Meng, Lisa;
Bian, Amy;
Lee, Jacqueline;
Wolff, Andrew A.;
Malik, Fady I.;
Shefner, Jeremy M.

Publication type:

Article

Discussing edaravone with the ALS patient: an ethical framework from a U.S. perspective.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 3/4, p. 167, doi. 10.1080/21678421.2018.1425455

By:

Yeo, Crystal Jing Jing;
Simmons, Zachary

Publication type:

Article

ALSUntangled 42: Elysium health’s “basis”.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 3/4, p. 317, doi. 10.1080/21678421.2017.1373978

By:

Bedlack, Richard;
The ALSUntangled Group

Publication type:

Article

A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018, v. 19, n. 3/4, p. 250, doi. 10.1080/21678421.2017.1404108

By:

Clawson, Lora L.;
Cudkowicz, Merit;
Krivickas, Lisa;
Brooks, Benjamin R.;
Sanjak, Mohammed;
Allred, Peggy;
Atassi, Nazem;
Swartz, Amy;
Steinhorn, Gabrielle;
Uchil, Alpa;
Riley, Kristen M.;
Yu, Hong;
Schoenfeld, David A.;
Maragakis, Nicholas J.

Publication type:

Article

Cost-effectiveness associated with amyotrophic lateral sclerosis: some questions and answers pending.

Published in:

2018

By:

Fiorentino, Giuseppe;
Esquinas, Antonio M.

Publication type:

Letter to the Editor

Theme 11: Improving diagnosis, prognosis and disease progression.

Published in:: 2017
Publication type:: Abstract

Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 49, doi. 10.1080/21678421.2017.1361443

By:

Takei, Koji;
Takahashi, Fumihiro;
Liu, Shawn;
Tsuda, Kikumi;
Palumbo, Joseph

Publication type:

Article

Poster Contents Page.

Published in:: 2017
Publication type:: Table of Contents

Theme 14 Multidisciplinary care and improving quality of life.

Published in:: 2017
Publication type:: Abstract

Theme 13 Respiratory and nutritional management.

Published in:: 2017
Publication type:: Abstract

Poster Subject Index.

Published in:: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, p. 333, doi. 10.1080/21678421.2017.1374635
Publication type:: Article

Theme 10 Therapeutic strategies.

Published in:: 2017
Publication type:: Abstract

Theme 5 Epidemiology.

Published in:: 2017
Publication type:: Abstract

Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 475, doi. 10.1080/21678421.2017.1332079

By:

Crook, Ashley;
Williams, Kelly;
Adams, Lorel;
Blair, Ian;
Rowe, Dominic B.

Publication type:

Article

Theme 7 Electrophysiology.

Published in:: 2017
Publication type:: Abstract

Theme 6 Biomarkers.

Published in:: 2017
Publication type:: Abstract

Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).

Published in:: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 20, doi. 10.1080/21678421.2017.1361441
Publication type:: Article

Theme 3 In vivo experimental models.

Published in:: 2017
Publication type:: Abstract

Theme 2 In vitro experimental models.

Published in:: 2017
Publication type:: Abstract

Comparison of slow and forced vital capacities on ability to predict survival in ALS.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 528, doi. 10.1080/21678421.2017.1354995

By:

Pinto, Susana;
de Carvalho, Mamede

Publication type:

Article

Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment*.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 519, doi. 10.1080/21678421.2017.1353098

By:

Hamidou, Bello;
Marin, Benoit;
Lautrette, Geraldine;
Nicol, Marie;
Camu, William;
Corcia, Philippe;
Arnes-Bes, Marie-Christine;
Tranchant, Christine;
Clavelou, Pierre;
Hannequin, Didier;
Maurice, Giroud;
Beauvais, Katell;
Antoine, Jean-Christophe;
Danel-Brunaud, Véronique;
Viader, Fausto;
Preux, Pierre-Marie;
Couratier, Philippe

Publication type:

Article

Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 511, doi. 10.1080/21678421.2017.1353097

By:

Enache, Irina;
Pistea, Cristina;
Fleury, Marie;
Schaeffer, Mickael;
Oswald-Mammosser, Monique;
Echaniz-Laguna, Andoni;
Tranchant, Christine;
Meyer, Nicolas;
Charloux, Anne

Publication type:

Article

The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 569, doi. 10.1080/21678421.2017.1349151

By:

Martin, Sarah;
Trevor-Jones, Emma;
Khan, Sabyha;
Shaw, Keelan;
Marchment, Deepti;
Kulka, Anna;
Ellis, Catherine E;
Burman, Rachel;
Turner, Martin R.;
Carroll, Liam;
Mursaleen, Leah;
Leigh, P. Nigel;
Shaw, Christopher E.;
Pearce, Neil;
Stahl, Daniel;
Al-Chalabi, Ammar

Publication type:

Article

International Survey of ALS Experts about Critical Questions for Assessing Patients with ALS.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 505, doi. 10.1080/21678421.2017.1349150

By:

De Carvalho, Mamede;
Ryczkowski, Adam;
Andersen, Peter;
Gromicho, Marta;
Grosskreutz, Julian;
Kuźma-Kozakiewicz, Magdalena;
Petri, Susanne;
Piotrkiewicz, Maria;
Miltenberger Miltenyi, Gabriel

Publication type:

Article

Split hand index and ulnar to median ratio in Hirayama disease and amyotrophic lateral sclerosis.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 598, doi. 10.1080/21678421.2017.1336561

By:

Kalita, Jayantee;
Kumar, Surendra;
Misra, Usha K.;
Neyaz, Zafar

Publication type:

Article

Effectiveness of assisted and unassisted cough capacity in amyotrophic lateral sclerosis patients.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 498, doi. 10.1080/21678421.2017.1335324

By:

Sancho, Jesús;
Servera, Emilio;
Bañuls, Pilar;
Marín, Julio

Publication type:

Article

Home care organization impacts patient management and survival in ALS.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 562, doi. 10.1080/21678421.2017.1332076

By:

Lavernhe, Sylvie;
Antoine, Jean-Christophe;
Court-Fortune, Isabelle;
Dimier, Nathalie;
Costes, Frédéric;
Lacour, Arnaud;
Camdessanché, Jean-Philippe

Publication type:

Article

A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Published in:: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 11, doi. 10.1080/21678421.2017.1363780
Publication type:: Article

Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.

Published in:: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 55, doi. 10.1080/21678421.2017.1364269
Publication type:: Article

Decision-making for tracheostomy in amyotrophic lateral sclerosis (ALS): a retrospective study.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 7/8, p. 492, doi. 10.1080/21678421.2017.1317812

By:

Ceriana, Piero;
Surbone, Sara;
Segagni, Daniele;
Schreiber, Annia;
Carlucci, Annalisa

Publication type:

Article

What can we learn from the edaravone development program for ALS?

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 98, doi. 10.1080/21678421.2017.1361446

By:

Maragakis, Nicholas J.

Publication type:

Article

An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 88, doi. 10.1080/21678421.2017.1361445

By:

Takei, Koji;
Tsuda, Kikumi;
Takahashi, Fumihiro;
Hirai, Manabu;
Palumbo, Joseph

Publication type:

Article

Pharmacokinetic profile of edaravone: a comparison between Japanese and Caucasian populations.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 80, doi. 10.1080/21678421.2017.1353100

By:

Nakamaru, Yoshinobu;
Kinoshita, Shuji;
Kawaguchi, Atsuhiro;
Takei, Koji;
Palumbo, Joseph;
Suzuki, Masayuki

Publication type:

Article

A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 71, doi. 10.1080/21678421.2017.1362440

By:

Kalin, Alexander;
Medina-Paraiso, Elvia;
Ishizaki, Kaoru;
Kim, Alex;
Zhang, Yannong;
Saita, Takanori;
Wasaki, Masahiko

Publication type:

Article

Post-hoc analysis of open-label extension period of study MCI186-19 in amyotrophic lateral sclerosis.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 64, doi. 10.1080/21678421.2017.1365372

By:

Takei, Koji;
Tsuda, Kikumi;
Takahashi, Fumihiro;
Palumbo, Joseph

Publication type:

Article

Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 32, doi. 10.1080/21678421.2017.1361442

By:

Takahashi, Fumihiro;
Takei, Koji;
Tsuda, Kikumi;
Palumbo, Joseph

Publication type:

Article

Edaravone and its clinical development for amyotrophic lateral sclerosis.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 5, doi. 10.1080/21678421.2017.1353101

By:

Takei, Koji;
Watanabe, Kazutoshi;
Yuki, Satoshi;
Akimoto, Makoto;
Sakata, Takeshi;
Palumbo, Joseph

Publication type:

Article

Introduction to supplement: the current status of treatment for ALS.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, p. 1, doi. 10.1080/21678421.2017.1361447

By:

Miller, Robert G.;
Appel, Stanley H.

Publication type:

Article

Slowly progressive motor neuron disease with multi-system involvement related to p.E121G SOD1 mutation.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 3/4, p. 296, doi. 10.1080/21678421.2016.1255756

By:

Taieb, Guillaume;
Polge, Anne;
Juntas-Morales, Raul;
Pageot, Nicolas;
Lumbroso, Serge;
Mouzat, Kevin;
Camu, William

Publication type:

Article

A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS.

Published in:

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2017, v. 18, n. 3/4, p. 243, doi. 10.1080/21678421.2016.1274330

By:

Thompson, Alexander G.;
Blackwell, Victoria;
Marsden, Rachael;
Millard, Emma;
Lawson, Clare;
Nickol, Annabel H.;
East, James E.;
Talbot, Kevin;
Allan, Philip J.;
Turner, Martin R.

Publication type:

Article